ARCHIVES

EntreMed Begins Phase I/II Trial For Endostatin.

This article is from The Cancer Letter archive.

Vol. 27 No. 30 | July 27, 2001

Download PDF Visit The Full Archive

Related Articles

NCI-Approved Clinical Trials

July 29, 2005

Also Von Eschenbach role in industry program raises new concerns of conflict of interest.

November 23, 2005

Biomedical Science Leadership is America’s Greatest Contribution, Benno Schmidt Says

August 14, 1987

Taxotere Encouraging, CPT-11, Other Agents Entering Trials; Chabner

July 10, 1992

NCI Hires Harold Freeman To Direct New Center For Study Of Health Disparities.

June 16, 2000

FDA Advisory Panel Unanimously Favors New Stool DNA Colorectal Screening Test

March 28, 2014